Qtick
Sign in

American Express Company (AXP) Competitors & Peers

The 5 largest companies in the same industry as American Express Company, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.

How we identify peers ↗

TickerRelationshipPriceComparables
VCompetitor$367.38P/E 31.0RSI 43Cap 683.9 B
MAPeer$567.65P/E 31.2RSI 47Cap 497.3 B
COFPeer$200.20P/E 11.0RSI 32Cap 120.3 B
PYPLPeer$55.04P/E 10.4RSI 52Cap 47.1 B
AFRMPeer$71.52P/E 12.8RSI 47Cap 23.9 B

How these relationships were derived

Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.

Model-inferred relationships (unverified)

Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.

  • GBTGPartner

    American Express is a major shareholder and licenses the 'American Express Global Business Travel' brand to GBTG.

    Model-inferred, unverified — treat as a lead, not evidence
  • DALPartner

    Delta SkyMiles co-brand cards exclusively with AmEx.

    Model-inferred, unverified — treat as a lead, not evidence
  • JPMCompetitor

    AmEx + Chase Sapphire compete in premium cards.

    Model-inferred, unverified — treat as a lead, not evidence
  • MARPartner

    Marriott Bonvoy co-brand cards issued with AmEx (US + EU).

    Model-inferred, unverified — treat as a lead, not evidence
  • HLTPartner

    Hilton Honors co-brand with AmEx.

    Model-inferred, unverified — treat as a lead, not evidence
  • VCompetitor

    Visa + AmEx compete (closed-loop vs open-loop).

    Model-inferred, unverified — treat as a lead, not evidence
  • BREXCompetitor

    Brex + AmEx corporate card overlap.

    Model-inferred, unverified — treat as a lead, not evidence
  • RAMPCompetitor

    Ramp + AmEx corporate-card overlap.

    Model-inferred, unverified — treat as a lead, not evidence